Varnotech is a biotechnology and pharmaceutical company that focuses on developing vaccines, antibodies, and adjuvants to combat diseases and viruses. Established in 2019, the company has attracted venture round investment from Watere Capital in February 2020. With a slogan that emphasizes its specialty in creating solutions to fight diseases and viruses, Varnotech is positioned to make significant contributions to the healthcare industry.
General Information
BounceWatch is an independent company data service, not affiliated with Varnotech. To contact Varnotech, visit varnotech.com.cn.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
Discover More
About Varnotech
Taxonomy: Vaccine development, Antibody research, Adjuvant technology, Disease prevention, Virus control, Immunology, Medical research, Innovation, Start-up, Biopharmaceuticals
Funding Rounds & Investors (1)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Venture Round | Undisclosed | 1 |
Watere Capital
|
01 Feb 2020 |
Varnotech Alternatives & Competitors
View All AlternativesAdvancing antibody therapeutics for combating diseases and targeting various biological threats.
Invest in Ruti Immune, developing a unique vaccine that enhances "trained innate immunity" against C...
HilleVax is a biopharmaceutical company focused on the development and commercialization of novel va...
FAQ About Varnotech
Source: BounceWatch company record for Varnotech, https://bouncewatch.com/company/varnotech, updated 30 December 2024. When citing, please name BounceWatch and link this page.